期刊文献+

PD-1基因启动子区域甲基化水平对慢性乙肝患者外周血单个核细胞上PD-1表达的影响 被引量:1

Demethylation pattern of PD-1 gene in promoter region is associated with the PD-1 expression onperipheral blood mononuclear cells in chronic hepatitis B patients
原文传递
导出
摘要 目的探讨慢性乙型肝炎(CHB)患者外周血单个核细胞(PBMCs)上程序性死TL=受体-1(PD-1)表达和PD-1启动子区域甲基化水平的差异及其影响因素,以及两者之间的关系。方法筛选2009年9月至2011年9月在中南大学湘雅二医院传染科门诊就诊144例CHB患者和18名健康献血员,流式细胞术(FCM)检测PBMCs表面表达PD-1的细胞比例,同时进行肝功能检测;时间分辨荧光免疫分析法检测CHB患者血清HBV标志物水平,荧光定量PCR检测血清HBVDNA载量;亚硫酸氢钠处理PBMCs细胞DNA,PCR扩增PD-1启动子基因片段,转化感受态大肠杆菌,挑克隆测序,检测扩增的PD-1启动子片段甲基化状态。结果与正常对照组(10.8%±4.4%)比较,CHB患者PBMCs上PD-1表达水平明显升高。在CHB患者中,PBMCs上PD-1表达在HBeAg阳性患者(27.1%±18.4%)中显著高于HBeAg阴性患者(19.6%±15.6%),PD-1表达水平与HBV-DNA和AIJT水平无明显相关性。PD-1启动子上多个CpG点(-601、-553、-538、-483、-463、-317bp)甲基化程度与PD-1在单个核细胞上的表达呈负相关。结论PD-1基因启动子区域甲基化水平可能影响CHB患者PBMCs上PD-1表达。 Objective To observe the expression variations and influencing factors of programmed death one (PD-1) and DNA demethylation of PD-1 promoter on peripheral blood mononuclear cells (PBMCs) in chronic hepatitis B (CHB) patients and further investigate the relationship between the demethylation pattern of PD-1 gene in promoter region and the PD-1 expression on PBMC in CHB patients. Methods A total of 162 subjects, including 144 CHB patients and 18 healthy blood donors, were enrolled. The expression of PD-I on PBMCs was detected by flow cytometry. And the serum HBV markers, HBV DNA load and liver function were also measured. DNA of PBMCs was treated with sodium bisulfite; the PD-1 promoter fragments were amplified by polymerase chain reaction (PCR) and then transformed into Escherichia coll. Positive clones were selected for sequencing and the methylation status of fragments of PD- 1 promoter was examined. Results With the PD-1 expression in normal controls ( 10. 8% ±4.4% ) as a baseline level, the expression of PD-1 in CHB patients significantly increased. In CHB patients, the serum expression of PD-lin PBMCs from patients with positive HBeAg (27. 1% ± 18.4% ) was much higher than that from those with negative HBeAg ( 19.6% ± 15.6% ) . And the expression level of PD-1 was not correlated with serum HBV DNA load and serum level of alanine aminotransferase. The results of bisulfitegenomic sequencing showed that demethylation probability of some CG points in PD-1 promoter region ( - 601, - 553, - 538, - 483, - 463, - 317 bp) were significantly correlated with PD-1 expression level ( P 〈 0. 05 ). Conclusion The demethylation pattern of PD-1 gene in promoter region is associated with the PD-1 expression on PBMC in CHB patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第5期336-340,共5页 National Medical Journal of China
基金 国家自然科学基金(30901269)
关键词 肝炎 乙型 转录启动子 程序性死亡受体-1 Hepatitis B Transcription initiation site Programmed death 1
  • 相关文献

参考文献20

  • 1Chen MT, Billaud JN, Sallberg M, et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A, 2004, 101:14913- 14918.
  • 2Milich DR, Jones JE, Hughes JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A, 1990, 87:6599-6603.
  • 3Holtby l, McCarron B. Immunisation of babies of women who screen positive for hepatitis B. Commun Dis Public Health, 2004, 7:258-259.
  • 4Peng G, Luo B, Li l, et al. Hepatitis B c-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB _p_atient_s_.J C!in Immunol,. 2011, 31:195-204. .
  • 5Kang EH, Kown TY, Oh GT, et al. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced bythe hepatitis B virus-e antigen. Antiviral Res, 2006, 72 : 100-106.
  • 6Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 2006, 439:682-687.
  • 7Loke P, Allison JP. PD-L1 and PD-L2 are differentially regulated by Thl and Th2 cells. Proc Natl Acad Sci U S A, 2003, 100: 5336-5341.
  • 8Sheppard KA, Fitz LJ, Lee JM, et al. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett, 2004, 574:37-41.
  • 9Loke P, Allison JP. Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells. Arthritis Res Ther, 2004, 6:208-214.
  • 10I Xie Z, Chert Y, Zhao S, et al. Intrahepatic PD-1/PD-LI up- regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection, lmmunol Invest, 2009, 38:624-638.

二级参考文献15

  • 1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
  • 9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
  • 10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.

共引文献734

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部